Inspira Technologies Oxy - רווח החברה לפני מסים, ריבית ופחת IINN

Inspira Technologies Oxy (IINN) is implementing a unique oxygenation system to save patients without the use of ventilators. Changes in EBITDA_Co illustrate current profit dynamics, with the indicator standing at 0.00. A startup culture providing R&D freedom for bioengineers serves as the solution to these challenges. A high barrier to entry and forthcoming patents create a defensive moat for the company until FDA approval is obtained.

This metric captures the daily cash flow from operating activities, excluding non-cash depreciation and amortization charges to assess the business's actual ability to generate cash. By analyzing the EBITDA_Co trend, an investor can see the net operating efficiency, which at Inspira Technologies Oxy (IINN) is maintained through production outsourcing, minimizing capital expenditures on equipment and eliminating the risk of losses from line downtime.